Related Experiment Videos

Crystallization and preliminary X-ray diffraction analysis of a functional form of pneumolysin, a virulence factor

S J Kelly1, M J Jedrzejas

  • 1Department of Microbiology, University of Alabama at Birmingham, AL 35294, USA.

Insights

Researchers crystallized pneumolysin, a key toxin from Streptococcus pneumoniae, bound to cholesterol. This structural study advances understanding of this bacterial pore-forming toxin and its role in disease.

Area of Science:

  • Microbiology
  • Structural Biology
  • Biochemistry

Background:

  • Pneumolysin is a critical virulence factor from Streptococcus pneumoniae, a leading cause of bacterial pneumonia and meningitis.
  • As a cholesterol-dependent cytolysin, pneumolysin forms pores in host cell membranes, contributing to disease pathogenesis.
  • Understanding pneumolysin's structure is crucial for developing targeted therapeutics.

Purpose of the Study:

  • To obtain a three-dimensional structure of pneumolysin in its active, cholesterol-bound form.
  • To characterize the crystal structure of pneumolysin complexed with cholesterol.
  • To provide insights into the mechanism of cholesterol-dependent cytolysins.

Main Methods:

  • Overexpression and purification of pneumolysin.
  • Crystallization of pneumolysin using vapor-diffusion with ammonium sulfate, n-octyl-beta-D-glucopyranoside, and phosphatidylcholine.
  • X-ray diffraction analysis of the pneumolysin-cholesterol complex.

Main Results:

  • Successfully crystallized pneumolysin (53 kDa) in complex with cholesterol.
  • The crystals diffracted X-rays to a resolution of 3.3 Å.
  • The crystal belongs to the trigonal space group P3 with specific unit cell parameters.
  • This is the first report of crystallizing a cholesterol-dependent cytolysin with bound cholesterol.

Conclusions:

  • The study reports the first successful crystallization of a cholesterol-dependent cytolysin bound to cholesterol.
  • The obtained crystal structure will enable detailed analysis of pneumolysin's mechanism of action.
  • This structural information is vital for future drug development against Streptococcus pneumoniae infections.

Related Concept Videos